Loading...
BioNTech SE
BNTX•NASDAQ
HealthcareBiotechnology
$97.27
$4.50(4.85%)
BioNTech SE (BNTX) AI-Powered Stock Analysis
See how BioNTech SE scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBioNTech SE (BNTX) Stock Overall Grade
BioNTech SE’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to BioNTech SE's overall stock rating.
Forecast
A+Score
100/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
51/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
70/100Component Analysis Explained
Understand the key factors behind each BioNTech SE stock grade, including financials, comparisons, and forecasts.